NASDAQ:ZYNE
Zynerba Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.zynerba.comipo date
Aug 05, 2015
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus